<?xml version="1.0" encoding="UTF-8"?>
<xml>
  <records>
    <record>
      <source-app name="Horizon">Horizon</source-app>
      <rec-number>1</rec-number>
      <foreign-keys>
        <key app="Horizon" db-id="fdi:010079204">1</key>
      </foreign-keys>
      <ref-type name="Journal Article">17</ref-type>
      <work-type>ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES</work-type>
      <contributors>
        <authors>
          <author>
            <style face="normal" font="default" size="100%">Demontès, M.</style>
          </author>
          <author>
            <style face="bold" font="default" size="100%">Eymard-Duvernay, Sabrina</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Allavena, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Jovelin, T.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Reynes, J.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Hentzien, M.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Ravaux, I.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Delobel, P.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Bregigeon, S.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Rey, D.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Ferry, T.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Gagneux-Brunon, A.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Robineau, O.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Pugliese, P.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Duvivier, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Cabié, A.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Chirouze, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Jacomet, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Lamaury, I.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Merrien, D.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Hoen, B.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Hocqueloux, L.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Cheret, A.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Katlama, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Arvieux, C.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Krolak-Salmon, P.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Makinson, A.</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">Delaporte, Eric</style>
          </author>
          <author>
            <style face="normal" font="default" size="100%">et al.</style>
          </author>
        </authors>
      </contributors>
      <titles>
        <title>Multimorbidity in elderly persons according to the year of diagnosis of human immunodeficiency virus infection : a cross-sectional dat’aids cohort study</title>
        <secondary-title>Clinical Infectious Diseases</secondary-title>
      </titles>
      <pages>art. ciz1171 [9 ]</pages>
      <keywords>
        <keyword>FRANCE</keyword>
      </keywords>
      <dates>
        <year>2020</year>
      </dates>
      <call-num>fdi:010079204</call-num>
      <language>ENG</language>
      <periodical>
        <full-title>Clinical Infectious Diseases</full-title>
      </periodical>
      <isbn>1058-4838</isbn>
      <accession-num>ISI:000607829500018</accession-num>
      <electronic-resource-num>10.1093/cid/ciz1171</electronic-resource-num>
      <urls>
        <related-urls>
          <url>https://www.documentation.ird.fr/hor/fdi:010079204</url>
        </related-urls>
        <pdf-urls>
          <url>https://horizon.documentation.ird.fr/exl-doc/pleins_textes/divers20-06/010079204.pdf</url>
        </pdf-urls>
      </urls>
      <volume>[Publ. online 2019/12/09]</volume>
      <remote-database-provider>Horizon (IRD)</remote-database-provider>
      <abstract>Background : We assessed prevalence of multimorbidity (MM) according to year of human immunodeficiency virus (HIV) diagnosis in elderly people living with HIV (PLWH). Methods : This was a cross-sectional study of MM in PLWH aged &gt;-70 years from the Dat'AIDS French multicenter cohort. MM was defined as at least 3 coexistent morbidities of high blood pressure, diabetes mellitus, osteoporosis, non-AIDS cancer, chronic renal failure, cardiovascular and cerebrovascular disease, obesity, undernutrition, or hypercholesterolemia. Logistic regression models evaluated the association between MM and calendar periods of HIV diagnosis (1983-1996, 1997-2006, and 2007-2018). The secondary analysis evaluated MM as a continuous outcome, and a sensitivity analysis excluded PLWH with nadir CD4 count &lt;200 cells/ul. Results : Between January 2017 and September 2018, 2476 PLWH were included. Median age was 73 years, 75% were men, median CD4 count was 578 cells/ul, and 94% had controlled viremia. MM prevalence was 71%. HBP and hypercholesterolemia were the most prevalent comorbidities. After adjustment for age, gender, smoking status, hepatitis C and hepatitis B virus coinfection, group of exposure, nadir CD4 count, CD4:CD8 ratio, and last CD4 level, calendar period of diagnosis was not associated with MM (P = .169). MM was associated with older age, CD4/CD8 ratio &lt;0.8, and nadir CD4 count &lt;200 cells/ul. Similar results were found with secondary and sensitivity analyses. Conclusions : MM prevalence was high and increased with age, low CD4/CD8 ratio, and nadir CD4 count &lt;200 cells/ul but was not associated with calendar periods of HIV diagnosis. Known duration of HIV diagnosis does not seem to be a criterion for selecting elderly PLWH at risk of MM.</abstract>
      <custom6>050 ; 052 ; 020</custom6>
      <custom1>UR233</custom1>
    </record>
  </records>
</xml>
